Why Guinea-Bissau halted a controversial hepatitis vaccine trial for babies
- Guinea-Bissau has reportedly halted a controversial United States-funded hepatitis B virus vaccine (HBV) trial which drew global scrutiny when experts said it involved withholding lifesaving shots from thousands of babies.
- The trial failed to gain the necessary government approval, one researcher involved in the project said in a statement, adding that the end of the trial was a “significant setback” for African science.
- Recommended Stories list of 4 itemslist 1 of 4Port Sudan families can barely afford water as shortages persistlist 2 of 4Israel restricting treatment for 1,100 child amputees in
Unverified
- Guinea-Bissau has reportedly halted a controversial United States-funded hepatitis B virus vaccine (HBV) trial which drew global scrutiny when experts said it involved withholding lifesaving shots from thousands of babies.
- The trial failed to gain the necessary government approval, one researcher involved in the project said in a statement, adding that the end of the trial was a “significant setback” for African science.
- Recommended Stories list of 4 itemslist 1 of 4Port Sudan families can barely afford water as shortages persistlist 2 of 4Israel restricting treatment for 1,100 child amputees in
Sources: Al Jazeera